Application of compound alfuzosin hydrochloride in preparing information therapy medicines, preparation method thereof and prepared novel medicine

A technology of alfuzosin hydrochloride and chemotherapeutic drugs, which is applied in the field of new alfuzosin hydrochloride drugs, and can solve dryness, nausea and vomiting, diarrhea, abdominal pain, indigestion, constipation, palpitations, orthostatic hypotension, edema, Dizziness, headache, inability to reapply, limit treatment effects and other problems, to avoid toxic side effects, increase use value, and overcome side effects

Inactive Publication Date: 2012-07-25
北京中卫神农慢性病医学研究院有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, alfuzosin hydrochloride is used as a chemotherapeutic drug, and there are defects that cannot be overcome so far. The first is the toxic and side effects on the human body, and its annoying adverse reactions include dry mouth, nausea and vomiting, diarrhea, abdominal pain , indigestion, constipation, palpitations, orthostatic hypotension, edema, dizziness, headache, impotence, allergies, etc.; second, the treatment window is small, and due to the toxic and side effects on the human body, the effective dose that can be used is very small, which limits the therapeutic effect , the maximum dose of oral administration is 5 mg once, 10 mg per day, and poisoning can occur if the maximum dose is exceeded; the third is that there is only one use of chemotherapy drugs, and the drugs will be metabolized or excreted when they enter the human body, and cannot be used for the second time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of compound alfuzosin hydrochloride in preparing information therapy medicines, preparation method thereof and prepared novel medicine
  • Application of compound alfuzosin hydrochloride in preparing information therapy medicines, preparation method thereof and prepared novel medicine
  • Application of compound alfuzosin hydrochloride in preparing information therapy medicines, preparation method thereof and prepared novel medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0044] Weigh the alfuzosin hydrochloride raw material (1) by the following weight: 300 grams of alfuzosin hydrochloride raw material (1) (content ≥ 99%), put the raw material (1) into the filling machine, press each bag with a microporous air-permeable paper bag The net weight of 10 grams is divided into 30 bags, which are heat-melted and sealed to make an alfuzosin hydrochloride drug information packing bag (3). Simultaneously, make magnetic suspension (card) (8) container (4) box 30 in addition. The manufacturing method of the magnetic suspension (card) (8) container (4) box is: use plastic mold injection molding to produce an oblate container (4) box with an inner hollow diameter of 5-10cm and a height of 0.5-1.5cm, and the container (4) box A number of holes (5) with a diameter of 0.1 cm are placed on the outside of the lower part, and a magnetic sheet (7) with a magnetic force of 500-1500 Gauss is placed on the concave surface of the top of the container (4), and a magnet...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses application of compound alfuzosin hydrochloride in preparing information therapy medicines, a preparation method thereof and a prepared novel medicine. The information therapy medicines are not directly contacted with the human body when being used for therapy, medicine substance components are not consumed, only medicine information is utilized for physical therapy, the effect of chemical therapy can be achieved, a therapy window is expanded by more than one thousand times, and the side effects of the chemical therapy are avoided. After the alfuzosin hydrochloride is used as the information therapy medicine, and the contents of effective components of the alfuzosin hydrochloride are not changed. The alfuzosin hydrochloride also can be used as a conventional chemical therapy preparation to be reused effectively.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a novel drug of alfuzosin hydrochloride. Background technique [0002] Compound Alfuzosin hydrochloride (Alfuzosin hydrochloride), chemical name: N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro -2-furan carboxamide hydrochloride, chemical formula C 19 h 27 N 5 o 4 HCl, molecular weight 425.91. Appearance is white crystalline powder. Alfuzosin hydrochloride is a drug for relieving benign prostatic hyperplasia, which is clinically used to treat benign prostatic hyperplasia and hypertension. The pharmaceutical preparations of alfuzosin hydrochloride include tablets, capsules and the like. Known alfuzosin hydrochloride drugs are all used as chemotherapeutic drugs, which is to allow the compound alfuzosin hydrochloride molecules to enter the human body (through oral absorption into the blood), distribute to various tissues, and through the chemical reaction of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/517A61K47/02A61P13/08A61P3/06
Inventor 杨孟君杨哲
Owner 北京中卫神农慢性病医学研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products